These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20347187)

  • 1. QSAR study of substituted 1,3,4-oxadiazole naphthyridines as HIV-1 integrase inhibitors.
    Ravichandran V; Shalini S; Sundram K; Sokkalingam AD
    Eur J Med Chem; 2010 Jul; 45(7):2791-7. PubMed ID: 20347187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of oxadiazole and triazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 1: Establishing the pharmacophore.
    Johns BA; Weatherhead JG; Allen SH; Thompson JB; Garvey EP; Foster SA; Jeffrey JL; Miller WH
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1802-6. PubMed ID: 19217781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors.
    Leonard JT; Roy K
    Eur J Med Chem; 2008 Jan; 43(1):81-92. PubMed ID: 17452064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,3,4-Oxadiazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 2: SAR of the C5 position.
    Johns BA; Weatherhead JG; Allen SH; Thompson JB; Garvey EP; Foster SA; Jeffrey JL; Miller WH
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1807-10. PubMed ID: 19217284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR study of carboxylic acid derivatives as HIV-1 Integrase inhibitors.
    Cheng Z; Zhang Y; Fu W
    Eur J Med Chem; 2010 Sep; 45(9):3970-80. PubMed ID: 20561721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of 5-(1-H or 1-alkyl-5-oxopyrrolidin-3-yl)-8-hydroxy-[1,6]-naphthyridine-7-carboxamide inhibitors of HIV-1 integrase.
    Melamed JY; Egbertson MS; Varga S; Vacca JP; Moyer G; Gabryelski L; Felock PJ; Stillmock KA; Witmer MV; Schleif W; Hazuda DJ; Leonard Y; Jin L; Ellis JD; Young SD
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5307-10. PubMed ID: 18774711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CoMFA and CoMSIA 3D-QSAR studies on quionolone caroxylic acid derivatives inhibitors of HIV-1 integrase.
    Lu P; Wei X; Zhang R
    Eur J Med Chem; 2010 Aug; 45(8):3413-9. PubMed ID: 20488589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivariate QSAR study of 4,5-dihydroxypyrimidine carboxamides as HIV-1 integrase inhibitors.
    de Melo EB; Ferreira MM
    Eur J Med Chem; 2009 Sep; 44(9):3577-83. PubMed ID: 19327872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the structural requirement for inhibiting HIV integrase: QSAR study.
    Dessalew N
    Acta Pharm; 2009 Mar; 59(1):31-43. PubMed ID: 19304556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antiviral activity of 7-benzyl-4-hydroxy-1,5-naphthyridin-2(1H)-one HIV integrase inhibitors.
    Boros EE; Edwards CE; Foster SA; Fuji M; Fujiwara T; Garvey EP; Golden PL; Hazen RJ; Jeffrey JL; Johns BA; Kawasuji T; Kiyama R; Koble CS; Kurose N; Miller WH; Mote AL; Murai H; Sato A; Thompson JB; Woodward MC; Yoshinaga T
    J Med Chem; 2009 May; 52(9):2754-61. PubMed ID: 19374386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repositioning HIV-1 integrase inhibitors for cancer therapeutics: 1,6-naphthyridine-7-carboxamide as a promising scaffold with drug-like properties.
    Zeng LF; Wang Y; Kazemi R; Xu S; Xu ZL; Sanchez TW; Yang LM; Debnath B; Odde S; Xie H; Zheng YT; Ding J; Neamati N; Long YQ
    J Med Chem; 2012 Nov; 55(22):9492-509. PubMed ID: 23098137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating chemical diversity in QSAR analysis: modeling diverse HIV-1 integrase inhibitors using 4D fingerprints.
    Iyer M; Hopfinger AJ
    J Chem Inf Model; 2007; 47(5):1945-60. PubMed ID: 17661457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A series of 5-aminosubstituted 4-fluorobenzyl-8-hydroxy-[1,6]naphthyridine-7-carboxamide HIV-1 integrase inhibitors.
    Guare JP; Wai JS; Gomez RP; Anthony NJ; Jolly SM; Cortes AR; Vacca JP; Felock PJ; Stillmock KA; Schleif WA; Moyer G; Gabryelski LJ; Jin L; Chen IW; Hazuda DJ; Young SD
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2900-4. PubMed ID: 16554152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel QSAR model for predicting the inhibition of CXCR3 receptor by 4-N-aryl-[1,4] diazepane ureas.
    Afantitis A; Melagraki G; Sarimveis H; Igglessi-Markopoulou O; Kollias G
    Eur J Med Chem; 2009 Feb; 44(2):877-84. PubMed ID: 18619714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D-QSAR studies of quinoline ring derivatives as HIV-1 integrase inhibitors.
    Sun XH; Guan JQ; Tan JJ; Liu C; Wang CX
    SAR QSAR Environ Res; 2012 Oct; 23(7-8):683-703. PubMed ID: 22991976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring binding mode for styrylquinoline HIV-1 integrase inhibitors using comparative molecular field analysis and docking studies.
    Ma XH; Zhang XY; Tan JJ; Chen WZ; Wang CX
    Acta Pharmacol Sin; 2004 Jul; 25(7):950-8. PubMed ID: 15210071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
    Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R
    Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of 8-hydroxy-[1,6]naphthyridines as novel inhibitors of HIV-1 integrase in vitro and in infected cells.
    Zhuang L; Wai JS; Embrey MW; Fisher TE; Egbertson MS; Payne LS; Guare JP; Vacca JP; Hazuda DJ; Felock PJ; Wolfe AL; Stillmock KA; Witmer MV; Moyer G; Schleif WA; Gabryelski LJ; Leonard YM; Lynch JJ; Michelson SR; Young SD
    J Med Chem; 2003 Feb; 46(4):453-6. PubMed ID: 12570367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cluster analysis and three-dimensional QSAR studies of HIV-1 integrase inhibitors.
    Yuan H; Parrill A
    J Mol Graph Model; 2005 Jan; 23(4):317-28. PubMed ID: 15670952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A series of 5-(5,6)-dihydrouracil substituted 8-hydroxy-[1,6]naphthyridine-7-carboxylic acid 4-fluorobenzylamide inhibitors of HIV-1 integrase and viral replication in cells.
    Embrey MW; Wai JS; Funk TW; Homnick CF; Perlow DS; Young SD; Vacca JP; Hazuda DJ; Felock PJ; Stillmock KA; Witmer MV; Moyer G; Schleif WA; Gabryelski LJ; Jin L; Chen IW; Ellis JD; Wong BK; Lin JH; Leonard YM; Tsou NN; Zhuang L
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4550-4. PubMed ID: 16102965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.